The journey from preclinical development to commercialization of a new biopharmaceutical is long and challenging. The entire process requires persistence, adaptability, and strategic foresight. Only with a well-coordinated effort across disciplines and business functions can a new biologic drug successfully advance from laboratory to market. Partnering with a CDMO can be invaluable in navigating such challenges to provide flexibility, enabling drug sponsors to focus on their core competencies while relying on their partners to handle the intricacies of manufacturing and regulatory compliance. Such partnerships can reduce risks significantly and help ensure that a new biologic reaches the market as efficiently as possible. Learn key considerations for the journey to commercialization. Register or Login and hit Download Now to get the full Special Report.

This webcast features: Angelines Castro Forero, PhD, filtration technology manager, & Hannah Hertrick , market development manager, Saint-Gobain Life Sciences. The integrity of filters used in critical bioprocesses is essential for product safety and compliance. This webinar provides a comprehensive overview of filter integrity test methods, exploring their definitions, methodologies, and the regulatory framework that shapes their use. Attendees will gain insights into pre-use and post-sterilization integrity testing (PUPSIT) while discovering effective troubleshooting strategies for common testing issues. Join Saint-Gobain to deepen your understanding of filter integrity testing as they explore the following topics: Register or Login and hit Watch on Demand to view the recorded webcast now.